Bio-Rad Laboratories, Inc. Share Price
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
01:30:02 14/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 363.73 USD | -0.19% |
|
-1.38% | +20.05% |
| Market Cap | 973.23Cr 869.39Cr 810.34Cr 734.67Cr 1.38TCr 92TCr 1.39TCr 9.71TCr 3.8TCr 48TCr 3.66TCr 3.57TCr 1,54200Cr | P/E 2026 * |
43.7x | P/E 2027 * | 42.7x |
|---|---|---|---|---|---|
| Enterprise Value | 898.33Cr 802.48Cr 747.98Cr 678.13Cr 1.28TCr 85TCr 1.29TCr 8.96TCr 3.51TCr 44TCr 3.37TCr 3.3TCr 1,42300Cr | EV / Sales 2026 * |
3.5x | EV / Sales 2027 * | 3.34x |
| Free-Float |
60.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BIO | Delayed | |
CBOE
| BIO | Real-time | |
|
Tradegate
| BUWA | Real-time | |
|
Deutsche Boerse AG
| BUWA | Delayed | |
|
Börse Stuttgart
| BUWA | Delayed | |
|
Boerse Muenchen
| BUWA | Real-time |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | -0.19% | ||
| 1 week | -1.38% | ||
| Current month | -3.70% | ||
| 1 month | -1.51% | ||
| 3 months | +22.23% | ||
| 6 months | +26.22% | ||
| Current year | +20.05% |
| 1 week | 353.97 |  | 372.59 |
| 1 month | 353.3 | | 390 |
| Current year | 236.73 | | 396.23 |
| 1 year | 236.73 | | 396.23 |
| 3 years | 211.43 | | 396.23 |
| 5 years | 211.43 | | 798.97 |
| 10 years | 154.89 | | 832.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 01/01/2003 |
| President | 61 | 09/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 15/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 01/01/2012 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 25/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 25/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/09/26 | Exercice | General Counsel | 1,841 | 0.0085% | ||
| 06/09/26 | Exercice | Chief Executive Officer | 8,764 | 0.0404% | ||
| 06/09/26 | Exercice | Chief Financial Officer | 3,854 | 0.0178% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.19% | -1.38% | +19.76% | +5.51% | 974.73Cr | |
| +0.78% | +4.53% | -21.90% | +12.92% | 18TCr | |
| +1.17% | +6.80% | -2.69% | +29.25% | 12TCr | |
| -0.02% | +1.56% | -22.57% | +9.57% | 11TCr | |
| -0.31% | -0.27% | -46.72% | -10.85% | 7.53TCr | |
| +1.55% | +4.34% | +4.14% | +74.68% | 6.2TCr | |
| +0.97% | +1.73% | +20.56% | +68.11% | 5.28TCr | |
| -0.80% | +3.92% | +0.38% | -27.57% | 5.15TCr | |
| -0.69% | +0.95% | -17.84% | +22.09% | 4.13TCr | |
| -1.00% | +2.00% | +30.46% | +11.64% | 3.24TCr | |
| Average | +0.15% | +2.50% | -3.64% | +19.54% | 7.27TCr | |
| Weighted average by Cap. | +0.41% | +3.34% | -11.46% | +19.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 256.95Cr 229.53Cr 213.94Cr 193.96Cr 365.03Cr 24TCr 367.9Cr 2.56TCr 1TCr 13TCr 964.99Cr 943.82Cr 41TCr | 262.42Cr 234.42Cr 218.5Cr 198.09Cr 372.8Cr 25TCr 375.73Cr 2.62TCr 1.02TCr 13TCr 985.54Cr 963.91Cr 42TCr |
| Net income | 22Cr 20Cr 19Cr 17Cr 32Cr 2.13TCr 32Cr 224.27Cr 88Cr 1.11TCr 84Cr 83Cr 3.56TCr | 23Cr 21Cr 19Cr 17Cr 33Cr 2.18TCr 33Cr 229.13Cr 90Cr 1.13TCr 86Cr 84Cr 3.64TCr |
| Net Debt | -75Cr -67Cr -62Cr -57Cr -106.41Cr -7.11TCr -107.24Cr -747.11Cr -292.47Cr -3.7TCr -281.3Cr -275.13Cr -12TCr | -97Cr -86Cr -80Cr -73Cr -137.15Cr -9.16TCr -138.23Cr -962.96Cr -376.97Cr -4.77TCr -362.57Cr -354.62Cr -15TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | $363.73 | -0.19% | 1,32,588 |
| 12/26/12 | $364.42 | -0.48% | 1,81,201 |
| 09/26/09 | $366.16 | +1.60% | 1,38,984 |
| 08/26/08 | $360.40 | -2.04% | 3,12,024 |
| 07/26/07 | $367.92 | -0.25% | 2,51,904 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
Select your edition
All financial news and data tailored to specific country editions
